Biopsies are recommended for new lesions and post-treatment evaluation, with PSMA PET scans used selectively. Here are expert answers to common questions about a prostate cancer experience, ...
What you need to know Prostate cancer is usually diagnosed using image guided needle biopsy. Approximately 70 000 such biopsies are performed annually in the UK,1 but these numbers have fallen since ...
Using AI to Measure Prostate Cancer Lesions Could Aid Diagnosis and Treatment Oct. 29, 2024 — Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are ...
Nov. 14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...
PSMA PET has been increasingly used in high-risk primary, recurrent, and metastatic prostate cancer patients. With its increasing use, we encounter several dural-based intracranial lesions such as ...
Various prostate cancer features are observed on MRI, some of which include prostate imaging reporting and data system (PI-RADS) scores, lesion scores, and radiologic T stage, the latter of which ...
“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, ...
lesion characteristics, history of prior biopsies, and AI evaluations, focusing mainly on the detection of clinically significant prostate cancer (csPCa) (International Society of Urological Pathology ...
The incidence of low- to intermediate-risk prostate cancer is rising owing to informal ... with a margin of normal tissue is possible. Index lesion ablation is emerging as a promising strategy.